The use of Carnicetine in patients with diabetic polyneuropathy
- Authors: Kamchatnov P.R1, Kabanov A.A1, Khanmurzaeva S.B2, Chugunov A.V1, Khanmurzaeva N.B2
-
Affiliations:
- N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
- Dagestan State Medical University
- Issue: Vol 19, No 2 (2017)
- Pages: 136-140
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94749
- ID: 94749
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
P. R Kamchatnov
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: pavkam7@gmail.com
д-р мед. наук, проф. каф. неврологии и нейрохирургии с курсом фак-та усовершенствования врачей лечебного фак-та ФГБОУ ВО «РНИМУ им. Н.И.Пирогова» 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
A. A Kabanov
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federationканд. мед. наук, доц. каф. неврологии и нейрохирургии с курсом фак-та усовершенствования врачей лечебного фак-та ФГБОУ ВО «РНИМУ им. Н.И.Пирогова» 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
S. B Khanmurzaeva
Dagestan State Medical Universityаспирант каф. неврологии, нейрохирургии и медицинской генетики лечебного фак-та ФГБОУ ВО ДГМУ 367000, Russian Federation, Makhachkala, pl. Lenina, d. 1
A. V Chugunov
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federationканд. мед. наук, доц. каф. неврологии, нейрохирургии и медицинской генетики лечебного фак-та ФГБОУ ВО «РНИМУ им. Н.И.Пирогова» 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
N. B Khanmurzaeva
Dagestan State Medical Universityканд. мед. наук, ассистент каф. клин. фармакологии ФГБОУ ВО ДГМУ 367000, Russian Federation, Makhachkala, pl. Lenina, d. 1
References
- Visser N, Notermans N, Linssen R et al. Incidence of polyneuropathy in Utrecht, the Netherlands. Neurology 2015; 84 (3): 259-64.
- Vincent A, Calabek B, Roberts L, Feldman E. Biology of diabetic neuropathy. Handb Clin Neurol 2013; 115: 591-606.
- Sachan D.S, Yatim A.M. Suppression of aflatoxin B1-induced lipid abnormalities and macromolecule - adduct formation by L-carnitine. J Environ Pathol Toxicol Oncol 1992; 11: 205-10.
- Mingrone G. Carnitine in type 2 diabetes. Ann N Y Acad Sci 2004; 1033: 99-107.
- Rahbar A.R, Shakerhosseini R, Saadat N et al. Effect of L-carnitine on plasma glycemic andlipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr 2005; 59: 592-6.
- Power R.A, Hulver M.W, Zhang J.Y et al. Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia 2007; 50: 824-832. doi: 10.1007/s00125-007-0605-4
- Faradji V, Sotelo J. Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand 1990; 81: 402-6.
- Levine J, Panchalingam K, Mc Clure R.J et al. Effects of acetyl - L - carnitine and myo - inositol on high - energy phosphate and membrane phospholipid metabolism in zebra fish: a 31P - NMR - spectroscopy study. Neurochem Res 2003; 28: 687-90.
- Vivoli E, Di Cesare Mannelli L et al. Acetyl - l - carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy. Neuroscience. 2010; 167: 1168-74. http://dx.doi.org/10.1016/j.neuroscience.2010.03.017.
- Sariola H, Saarma M. Novel functions and signalling pathways for GDNF. J CellSci 2003; 116 (Pt 19): 3855-62.
- Baloh R.H, Tansey M.G, Lampe P.A et al. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron 1998; 21 (6): 1291-302.
- Traina G. The neurobiology of acetyl - L - carnitine. Front Biosci (Landmark Ed) 2016; 21: 1314-29.
- Ido Y, Mc Howat J, Chang K.C et al. Neural dysfunction and metabolic imbalances in diabetic rats: prevention by acetyl - L - carnitine. Diabetes 1994; 43: 1469-77. http://dx.doi.org/10.2337/di-abetes. 43.12.1469
- Chiechio S, Copani A, Iv R.W.G, Nicoletti F. Acetyl - L - carnitine in neuropathic pain. CNS Drugs 2007; 21 (1): 31-8.
- Malaguarnera M. Carnitine derivatives: clinical usefulness. Curr Opin Gastroenterol 2012; 28: 166-76. http://dx.doi.org/10.1097/MOG.0b013e3283505a3b
- Watson J.C, Dyck P.J.B. Peripheral neuropathy: a practical approach to diagnosis and symptom management. Mayo Clin Proc 2015; 90: 940-51. http:// dx.doi.org/10.1016/j.mayocp.2015.05.004.
- Acetyl - L - carnitine. Monograph. Altern Med Rev 2010; 15: 76-83.
- Curti D, Dagani F, Galmozzi M.R, Marzatico F. Effect of aging and acetyl - L - carnitine on energetic and cholinergic metabolism in rat brain regions. Mech Ageing Dev 1989; 47: 39-45. PMID: 2542702
- Onofrj M, Ciccocioppo F, Varanese S et al. Acetyl - L - carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond. Expert Rev Neurother 2013; 13: 925-36. doi: 10.1586/14737175.2013.814930 PMID: 23965166
- Scarpini E, Doneda P, Pizzul S et al. L-carnitine and acetyl - L - carnitine in human nerves from normal and diabetic subjects. J Peripher Nerv Syst 1996; 1: 157-63.
- Li S, Li Q, Li Y et al. Acetyl - L - carnitine in the treatment of peripheral neuropathic pain: a systematic review and meta - analysis of randomized controlled trials. Plos One 2015; 10: 1-10. http://dx.doi.org/10.1371/ journal.pone.0119479.
- Pessoa B, Escudeiro G, Nascimento O. Emerging Treatments for Neuropathic Pain. Curr Pain Headache Rep 2015; 19: 56-60.
- De Grandis D, Minardi C. Acetyl - L - carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long - term, randomised, double - blind, placebo - controlled study. Drugs R&D 2002; 3: 223-31.
- Sima A.A, Calvani M, Mehra M, Amato A. Acetyl - l - carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy an analysis of two randomized placebo - controlled trials. Diabetes Care 2005; 28: 89-94.
- Li S, Chen X, Li Q et al. Effects of acetyl - L - carnitine andmethylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double - blind, controlled trial. J Diabetes Invest 2016; 7: 777-785. doi: 10.1111/jdi.12493
- Veronese N, Sergi G, Stubbs B, the EUGMS special interest group on diabetes. Effect of acetyl - l - carnitine in the treatment of diabetic peripheral neuropathy: A systematic review and meta - analysis. Eur Geriatr Med 2017. http://dx.doi.org/10.1016/j.eurger.2017.01.002
- Mondal S, Choudhury K.B, Sharma S et al. Comparative study among glutamine, acetyl - L - carnitine, vitamin - E and methylcobalamine for treatment of paclitaxel - induced peripheral neuropathy. Clin Cancer Investig J 2014; 3: 213-9.
- Youle M, Osio M. A double - blind, parallel - group, placebo - controlled, multicentre study of acetyl L - carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med 2007; 8: 241-50.
- Herzmann C, Johnson M.A, Youle M. Long - term effect of acetyl - L - carnitine for antiretroviral toxic neuropathy. HIV ClinTrials 2005; 6: 344-50.